AP

Akhilendra Pratap Singh

Active Director Managing Director DIN 10138406
DIN 10138406 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Akhilendra Pratap Singh

Data last updated:

Akhilendra Pratap Singh is a Managing Director at Aur Healthcare Private Limited (since 2023). The company operates in Pharma.

DIN 10138406
Primary Designation Managing Director
Industry Pharma
First Appointment 28 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aur Healthcare Private Limited U46497UP2023PTC181057
Managing Director28 Apr 20232023Active

Board colleagues of Akhilendra Pratap Singh

NameDINCompanyDesignation
Ruchi Singh10138407Aur Healthcare Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Aur Healthcare Private Limited
Premium access

Shareholding and investment profile for Akhilendra Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhilendra Pratap Singh

Akhilendra Pratap Singh currently holds 1 directorship: Aur Healthcare Private Limited (Managing Director, since 28 Apr 2023).

Akhilendra Pratap Singh was first appointed on 28 Apr 2023 as Managing Director at Aur Healthcare Private Limited.

The current boards of Akhilendra Pratap Singh's companies include Ruchi Singh (Aur Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available